Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07420140

Evaluation of a Wearable PAP Device in a Tethered Configuration for the Treatment of Obstructive Sleep Apnoea.

Evaluation of a Wearable PAP Device in a Tethered Configuration for the Treatment of Obstructive Sleep Apnea.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
ResMed · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Each participant will wear a wearable PAP device, tethered to a released PAP device for up to 7 nights. Objectives include collecting and evaluating participants feedback on seal, comfort and usability of the wearable PAP device.

Detailed description

The wearable PAP study evaluates the APL mask system, a wearable PAP interface concept designed to explore alternative form factors that may improve comfort, wearability, and user acceptance of PAP therapy. This study aims to generate early human-use insights on the APL mask system when used in a tethered configuration with a commercially available PAP device, to inform design refinement. The study will follow a phased approach, enrolling small cohorts of participants per phase. The study population includes internal participants (Resmed employees, with and without OSA) and external participants with diagnosed OSA who are established PAP users. Approximately 5-15 participants will be enrolled per phase. Participants who meet the inclusion criteria, and whom provide written consent, will attend an in-person visit, followed by up to seven consecutive nights of at-home use of the APL mask system. The participants will complete a questionnaire following use of the device, before returning equipment in a second visit.

Conditions

Interventions

TypeNameDescription
DEVICEPositive Airway PressureThe investigational intervention is the APL mask system, consisting of a nasal mask cushion integrated into a weighted eye mask and headgear. The system is used in a tethered configuration via a released AirFit™ N20 short tube elbow and AirSense™ 11 ClimateLine™ tubing to a commercially available Resmed AirSense™ 11 PAP therapy device.

Timeline

Start date
2026-03-01
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2026-02-19
Last updated
2026-02-19

Source: ClinicalTrials.gov record NCT07420140. Inclusion in this directory is not an endorsement.